Scinai Immunotherapeutics Ltd. Research And Development Expense

• Scinai Immunotherapeutics Ltd. showed an increase of +6.2% in Research And Development Expense from 2023 to 2024.
• This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
• XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2015 to 2024), Scinai Immunotherapeutics Ltd.'s Research And Development Expense has declined by 30.0%.
• Historical annual values: Fiscal year 2024: $5.53 million | Fiscal year 2023: $5.21 million | Fiscal year 2022: $5.77 million | Fiscal year 2021: $3.25 million | Fiscal year 2020: $51.46 million | Fiscal year 2019: $68.65 million | Fiscal year 2018: $71.91 million | Fiscal year 2017: $18.78 million | Fiscal year 2016: $7.79 million | Fiscal year 2015: $7.91 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026